UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 15, 2018
OMEROS CORPORATION
(Exact name of Registrant as Specified in Its Charter)
| Washington | 001-34475 | 91-1663741 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) | ||
| 201 Elliott Avenue West Seattle, WA |
98119 | |||
| (Address of Principal Executive Offices) | (Zip Code) | |||
Registrant’s Telephone Number, Including Area Code: (206) 676-5000
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
The 2018 Annual Meeting of Omeros Corporation, or Omeros, was held on June 15, 2018. Shareholders of record at the close of business on April 12, 2018 were entitled to vote up to 48,286,842 shares of common stock at the annual meeting. A total of 41,107,604 shares (85.13%) were represented at the annual meeting in person or by proxy. Set forth below is a brief description of each matter voted upon at the annual meeting and the final voting results for each matter.
| (1) | The election of the following two Class III directors, each to serve until the 2021 Annual Meeting of Shareholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal: |
| For |
Withheld |
Broker Non-Votes | ||||
| Gregory A. Demopulos, M.D. |
17,780,436 | 349,868 | 22,977,300 | |||
| Leroy E. Hood, M.D., Ph.D. |
16,802,912 | 1,327,392 | 22,977,300 |
| (2) | The ratification of the appointment of Ernst & Young LLP as Omeros’ independent registered public accounting firm for the fiscal year ending December 31, 2018. |
| For |
Against |
Abstain |
Broker Non-Votes | |||
| 40,648,141 | 168,148 | 291,315 | 0 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| OMEROS CORPORATION | ||||||
| Date: June 18, 2018 | By: | /s/ Gregory A. Demopulos | ||||
| Gregory A. Demopulos, M.D. | ||||||
| President, Chief Executive Officer and Chairman of the Board of Directors | ||||||